Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 382

Related Citations for PubMed (Select 17665285)

1.

Plasma kynurenine and related measures in tic disorder patients.

Hoekstra PJ, Anderson GM, Troost PW, Kallenberg CG, Minderaa RB.

Eur Child Adolesc Psychiatry. 2007 Jun;16 Suppl 1:71-7. doi: 10.1007/s00787-007-1009-1. Erratum in: Eur Child Adolesc Psychiatry. 2007 Dec;16(8):537.

PMID:
17665285
2.

Tryptophan degradation in patients with gynecological cancer correlates with immune activation.

Schroecksnadel K, Winkler C, Fuith LC, Fuchs D.

Cancer Lett. 2005 Jun 8;223(2):323-9. Epub 2004 Dec 8.

PMID:
15896467
3.

Increased plasma kynurenine and its relationship to neopterin and tryptophan in Tourette's syndrome.

Rickards H, Dursun SM, Farrar G, Betts T, Corbett JA, Handley SL.

Psychol Med. 1996 Jul;26(4):857-62.

PMID:
8817721
4.

Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort.

Clarke G, Fitzgerald P, Cryan JF, Cassidy EM, Quigley EM, Dinan TG.

BMC Gastroenterol. 2009 Jan 20;9:6. doi: 10.1186/1471-230X-9-6.

5.

Decreased plasma tryptophan in pregnancy.

Schröcksnadel H, Baier-Bitterlich G, Dapunt O, Wachter H, Fuchs D.

Obstet Gynecol. 1996 Jul;88(1):47-50.

PMID:
8684760
6.

Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection.

Zangerle R, Widner B, Quirchmair G, Neurauter G, Sarcletti M, Fuchs D.

Clin Immunol. 2002 Sep;104(3):242-7.

PMID:
12217334
7.

Monitoring of immune activation using biochemical changes in a porcine model of cardiac arrest.

Amann A, Widner B, Rieder J, Antretter H, Hoffmann G, Mayr V, Strohmenger HU, Fuchs D.

Mediators Inflamm. 2001 Dec;10(6):343-6.

8.

Kynurenine and neopterin levels in patients with rheumatoid arthritis and osteoporosis during drug treatment.

Forrest CM, Kennedy A, Stone TW, Stoy N, Darlington LG.

Adv Exp Med Biol. 2003;527:287-95.

PMID:
15206742
9.

Increased neopterin production and tryptophan degradation in advanced Parkinson's disease.

Widner B, Leblhuber F, Fuchs D.

J Neural Transm. 2002 Feb;109(2):181-9.

PMID:
12075858
10.

Measurement of tryptophan, kynurenine and neopterin in women with and without postpartum blues.

Kohl C, Walch T, Huber R, Kemmler G, Neurauter G, Fuchs D, Sölder E, Schröcksnadel H, Sperner-Unterweger B.

J Affect Disord. 2005 Jun;86(2-3):135-42.

PMID:
15935232
11.

Tryptophan degradation in multiple trauma patients: survivors compared with non-survivors.

Ploder M, Spittler A, Schroecksnadel K, Neurauter G, Pelinka LE, Roth E, Fuchs D.

Clin Sci (Lond). 2009 Apr;116(7):593-8. doi: 10.1042/CS20080319.

12.

Longitudinal study of tryptophan degradation during and after pregnancy.

Schröcksnadel K, Widner B, Bergant A, Neurauter G, Schennach H, Schröcksnadel H, Fuchs D.

Life Sci. 2003 Jan 3;72(7):785-93.

PMID:
12479977
13.

Tryptophan degradation and neopterin levels in treated rheumatoid arthritis patients.

Ozkan Y, Mete G, Sepici-Dincel A, Sepici V, Simsek B.

Clin Rheumatol. 2012 Jan;31(1):29-34. doi: 10.1007/s10067-011-1767-5. Epub 2011 May 10.

PMID:
21556779
14.

Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection.

Neurauter G, Zangerle R, Widner B, Quirchmair G, Sarcletti M, Fuchs D.

Adv Exp Med Biol. 2003;527:317-23.

PMID:
15206745
15.

Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection.

Fuchs D, Möller AA, Reibnegger G, Werner ER, Werner-Felmayer G, Dierich MP, Wachter H.

Immunol Lett. 1991 Jun;28(3):207-11.

PMID:
1909303
16.

Immune system modulation in patients with malignant and benign breast disorders: tryptophan degradation and serum neopterin.

Girgin G, Tolga Sahin T, Fuchs D, Kasuya H, Yuksel O, Tekin E, Baydar T.

Int J Biol Markers. 2009 Oct-Dec;24(4):265-70.

PMID:
20082276
17.

Prognostic value of tryptophan load test followed by serum kynurenine determination. Its comparison with pyridoxal-5-phosphate, kynurenine, homocysteine and neopterin amounts.

Rudzite V, Fuchs D, Kalnins U, Jurika E, Silava A, Erglis A, Trusinskis K, Jegere S.

Adv Exp Med Biol. 2003;527:307-15.

PMID:
15206744
18.

Bariatric surgery cannot prevent tryptophan depletion due to chronic immune activation in morbidly obese patients.

Brandacher G, Winkler C, Aigner F, Schwelberger H, Schroecksnadel K, Margreiter R, Fuchs D, Weiss HG.

Obes Surg. 2006 May;16(5):541-8.

PMID:
16687019
19.

Tryptophan degradation and serum neopterin concentrations in intensive care unit patients.

Girgin G, Sahin TT, Fuchs D, Yuksel O, Kurukahvecioglu O, Sare M, Baydar T.

Toxicol Mech Methods. 2011 Mar;21(3):231-5. doi: 10.3109/15376516.2010.545960. Epub 2011 Jan 20.

PMID:
21247367
20.

Degradation of tryptophan in neurodegenerative disorders.

Widner B, Leblhuber F, Walli J, Tilz GP, Demel U, Fuchs D.

Adv Exp Med Biol. 1999;467:133-8.

PMID:
10721050
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk